Sources of nitrogen as rate-limiting factors for purine biosynthesis de novo in Ehrlich ascites tumor cells

1969 ◽  
Vol 177 (1) ◽  
pp. 88-93 ◽  
Author(s):  
Lydia J. Fontenelle ◽  
J.Frank Henderson
1974 ◽  
Vol 52 (3) ◽  
pp. 263-267 ◽  
Author(s):  
Floyd F. Snyder ◽  
J. Frank Henderson

Actinomycin D treatment of Ehrlich ascites tumor cells in vitro causes slight to moderate inhibition of purine ribonucleotide synthesis de novo and from purine bases, and strong inhibition of inosinate dehydrogenase activity. These effects have the same dose–response relationship as inhibition of RNA synthesis by this drug. Daunomycin has similar effects on purine metabolism at a concentration that substantially inhibits nucleic acid synthesis. Actinomycin D treatment leads to elevated intracellular concentrations of ATP and GTP, and the effects of this drug on purine metabolism are believed to be mediated by these purine ribonucleoside triphosphates.


1969 ◽  
Vol 47 (4) ◽  
pp. 419-422 ◽  
Author(s):  
Lydia J. Fontenelle ◽  
J. Frank Henderson

Incubation of tumor cells with formiminoglutamate leads to inhibition of lactate synthesis from glucose, inhibition of phosphoribosyl pyrophosphate synthesis, and inhibition of purine ribonucleotide synthesis de novo and from purine bases. Lactate synthesis from inosine was increased. These effects may result from inhibition of triose phosphate isomerase by a metabolite of formiminoglutamate.


Sign in / Sign up

Export Citation Format

Share Document